Jolan Pty Ltd v Essential Investments Pty Ltd (No 3)

Link copied
Case Copied 29 min read

FEDERAL COURT OF AUSTRALIA

Jolan Pty Ltd v Essential Investments Pty Ltd (No 3) [2021] FCA 1627  

File number(s): QUD 101 of 2021
Judgment of: DOWNES J
Date of judgment: 21 December 2021
Catchwords:

CORPORATIONS – oppression proceedings – appropriate remedy pursuant to s 233 Corporations Act 2001 (Cth) – existing and proposed shareholders are prepared and able to purchase plaintiff’s shares – whether consideration of other remedies should be deferred to enable shares to be acquired

COSTS – whether indemnity costs order should be made against defendants – whether unreasonable not to accept settlement offers made by plaintiff – whether allegations made by defendants which should never have been made – whether defendants’ conduct of proceedings contrary to overarching purpose of civil practice and procedure provisions of Federal Court of Australia Act 1976 (Cth) and Federal Court Rules 2011 (Cth) – whether costs order should be made against second to fourth defendants when no order otherwise made against them

Legislation:

Corporations Act 2001 (Cth) s 233

Federal Court of Australia Act 1976 (Cth) ss 37M(1), 37N(1)

Federal Court Rules 2011 (Cth) r 25.01(1)

Cases cited:

Alhalek v Quintiliani trading as Kells Lawyers (No 3) [2021] FCAFC 150

Anchorage Capital Partners Pty Limited v ACPA Pty Ltd (No 2) [2018] FCAFC 112

CGU Insurance Ltd v Corrections Corporation of Australia Staff Superannuation Ltd (2008) 15 ANZ Insurance Cases 61-785; [2008] FCAFC 173

Colgate-Palmolive Co v Cussons Pty Ltd [1993] FCA 801; (1993) 46 FCR 225

Dukemaster Pty Ltd v Bluehive Pty Ltd [2003] FCAFC 1

Hardingham v RP Data Pty Limited (No 2) [2021] FCAFC 175

Jolan Pty Ltd v Essential Investments Pty Ltd (No 2) [2021] FCA 1533

Division: General Division
Registry: Queensland
National Practice Area: Commercial and Corporations
Sub-area: Corporations and Corporate Insolvency
Number of paragraphs: 71
Date of last submissions: 17 December 2021
Date of hearing: Determined on the papers
Counsel for the Plaintiff: Mr S Webster with Ms M Barnes
Solicitor for the Plaintiff: Holding Redlich
Counsel for the Defendants: Mr J Peden QC with Mr E Robinson
Solicitor for the Defendants: Cronin Miller Litigation

ORDERS

QUD 101 of 2021
BETWEEN:

JOLAN PTY LTD ACN 613 047 448

Plaintiff

AND:

ESSENTIAL INVESTMENTS PTY LTD ACN 610 685 535

First Defendant

TODD HISCOCK

Second Defendant

TL HISCO INVESTMENTS PTY LTD ACN 612 008 910 (and another named in the Schedule)

Third Defendant

ORDER MADE BY:

DOWNES J

DATE OF ORDER:

21 DECEMBER 2021

In this Order:

(a)Shareholders’ Agreement means the agreement which is annexure “JM-11” to the affidavit of James McWilliam affirmed 18 June 2021;

(b)Undertaking means any one of the undertakings which is annexure “SLM-2” to the affidavit of Stacy Miller sworn 13 December 2021.

THE COURT ORDERS THAT:

1.The plaintiff and the first defendant shall take all reasonable steps to cause the completion of the sale of the shares owned by the plaintiff in the first defendant to any interested existing shareholder of the first defendant and any person who has signed an undertaking,…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Jolan Pty Ltd v Essential Investments Pty Ltd (No 3) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] FCA 1627
Decision Date

CaseChat Overview and Summary

The case before the Court was between Jolan Pty Ltd, the plaintiff, and Essential Investments Pty Ltd, the first defendant, with other defendants also involved. The plaintiff sought relief under section 233 of the Corporations Act 2001 (Cth) due to oppressive conduct by the defendants. The trial judgment, delivered on 7 December 2021, found that the plaintiff had established its claims and was entitled to relief. The primary legal issues addressed by the Court were the appropriate form of final orders to be made and the costs to be awarded. Specifically, the Court needed to determine whether to defer considering other remedies to allow the purchase of the plaintiff’s shares by existing shareholders, and whether an indemnity costs order should be made against the defendants.

The Court decided that the appropriate course was to make orders appointing liquidators and for winding up the company, but to stay these orders to enable shareholders and the company to purchase all of the plaintiff’s shares. The Court fixed the price of the plaintiff’s shares at $1.16 per share. The Court further ordered that the plaintiff and the first defendant must take all reasonable steps to complete the sale of the plaintiff’s shares to interested existing shareholders and any person who signed an undertaking, at the aforementioned price, as soon as practicable but no later than 14 January 2022. The Court found that the defendants’ conduct of the proceedings was contrary to the overarching purpose of the Federal Court of Australia Act 1976 (Cth) and the Federal Court Rules 2011 (Cth). Consequently, the Court ordered the first defendant to pay 90% of the plaintiff’s costs on the indemnity basis. The Court also noted that if all of the plaintiff’s shares were acquired by 14 January 2022, the hearing scheduled for 17 January 2022 would be vacated.

The Court issued several orders, including that the plaintiff and the first defendant should complete the sale of the plaintiff’s shares by 14 January 2022. If the sale was completed and the plaintiff was paid by that date, the hearing on 17 January 2022 would be vacated. The Court also granted the parties liberty to apply for further orders with three days’ written notice. Finally, the Court ordered the first defendant to pay 90% of the plaintiff’s costs on the indemnity basis.

Orders

Orders of the court

1. The plaintiff and the first defendant shall take all reasonable steps to cause the completion of the sale of the shares owned by the plaintiff in the first defendant to any interested existing shareholder of the first defendant and any person who has signed an undertaking, at a price of $1.16 per share, as soon as practicable.

2. By no later than 14 January 2022, any sale of the shares owned by the plaintiff in the first defendant as described in order 1 shall be completed.

3. For the purposes of orders 1 and 2, clauses 7.1, 7.2, 7.3, 7.4, 7.5, 7.6, 7.7 and 7.10 of the Shareholders’ Agreement do not apply.

4. The matter be listed for a further hearing at 9.30am (AEST) on 17 January 2022 for the making of further orders.

5. In the event that, prior to or on 14 January 2022:

(a) all of the plaintiff’s shares in the first defendant have been acquired in accordance with orders 1 and 2 above; and

(b) the plaintiff has been paid for the acquisition of all of its shares in the first defendant under orders 1 and 2 above,

the plaintiff shall advise the Court of those facts and the hearing on 17 January 2022 will be vacated.

6. The parties have liberty to apply on 3 days’ written notice.

7. The first defendant shall pay 90% of the plaintiff’s costs of and incidental to the proceedings on the indemnity basis.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

The case involves Jolan Pty Ltd, a company, and Essential Investments Pty Ltd, a shareholder of Jolan. Jolan had filed a claim under section 233 of the Corporations Act 2001 (Cth) seeking relief on the basis of oppressive conduct by the directors of the company. The claim was established at trial, leading to a determination that relief should be granted to Jolan. The court fixed the price of Jolan's shares at $1.16 per share, totaling $1,160,000. It was determined that existing shareholders of the company should have the first right to purchase Jolan’s shares at this price. If the shares were not fully acquired by a certain date, the company would be wound up and liquidators would be appointed. The court stayed the winding up order to allow time for the shares to be acquired.

The case came before the Court following a trial held in September and early October 2021, with judgment delivered on 7 December 2021. The parties were invited to file submissions on the appropriate form of final orders to be made, and to provide affidavit material relating to the appropriate costs order. Jolan filed submissions on 13 December 2021, followed by reply submissions on 17 December 2021. The defendants also filed submissions on 13 December 2021, along with an affidavit from Ms Stacy Miller, a partner at Cronin Miller Litigation, the solicitors for the defendants.

Decision

Reasons for decision

Following a trial held in September and early October 2021, the Court delivered judgment in this matter on 7 December 2021: Jolan Pty Ltd v Essential Investments Pty Ltd (No 2) [2021] FCA 1533 (trial judgment). Orders were also made on that date allowing the parties, existing shareholders of the Company and any interested persons to file and serve any written submissions on the appropriate form of final orders to be made. The parties were also invited to file and serve submissions and affidavit material relating to the appropriate costs order to be made. At [25] of the trial judgment, it was found that Jolan had established its claims and was entitled to relief under s 233 of the Corporations Act. At [403] of that decision, it was stated that:As submitted by the defendants, I agree that existing shareholders of the Company should have first right at purchasing Jolan’s shares at the price determined by the Court on the basis any clauses in the shareholders’ agreement relating to pre-emptive rights will not apply. At [473] of that decision, the price of Jolan’s shares was fixed at $1.16 per share or $1,160,000. At [492] – [494] of that decision, it was stated that:If there remains any of Jolan’s shares which have not been acquired by any shareholder, then the Company will be ordered to buy back the balance of Jolan’s shares which is not otherwise acquired at the price of $1.16 per share, with an appropriate reduction in the share capital of the Company. If, for any reason, Jolan’s shares have not been acquired by a particular date, then the Company will be wound up and Mr Anthony Norman Connelly and Mr William James Harris will be appointed as liquidators of the Company. Subject to receiving further submissions, my present view is that the appropriate course is to make the orders appointing the liquidators to the Company, and for an order winding up the Company, but then staying those orders to a particular date to enable the shareholders and the Company to buy all of Jolan’s shares. If the acquisition of Jolan’s shares is successful (whether by the shareholders and the Company, or just the shareholders) and Jolan ceases to be a shareholder, then the winding up order can then be vacated. As to the issue of the final orders which should be made, Jolan filed submissions on 13 December 2021 and, pursuant to a request of the parties, reply submissions on 17 December 2021. The defendants filed submissions on 13 December 2021 and an affidavit of Ms Stacy Miller sworn 13 December 2021. Other than the parties, no submissions were received from any shareholder or interested person. By her affidavit, Ms Miller, partner of Cronin Miller Litigation (CML), the solicitors for the defendants, swore an affidavit which deposed to the effect that:(a)all of the Company’s shareholders had been sent a copy of the trial judgment and orders made on 7 December 2021;(b)all but four shareholders had been approached to ascertain whether they intended to participate in the purchase of Jolan’s shares at $1.16 per share. [According to page 28 paragraph 9 of the defendants’ closing submissions, there are over 30 shareholders at present, which means that the vast majority of shareholders had been approached by 13 December];(c)eight existing shareholders and two incoming shareholders intend to participate in the purchase of Jolan’s shares at $1.16 per share;(d)each of those parties has deposited funds into the CML trust account such that it holds $1,160,000 in cleared funds for the purposes of that purchase;(e)each of those parties has signed an undertaking to acquire a certain number of Jolan’s shares. [When added together, the amounts referred to in these undertakings add up to 1,000,000 shares. Some of these undertakings are dated as early as 8 December 2021, being the day after the trial judgment was delivered].

Ratio Decidendi

Legal Principle Established

The Court considered the relief sought under s 233 of the Corporations Act 2001 (Cth) and found that the existing shareholders of the company should have the first right to purchase the plaintiff's shares at the price determined by the Court. The Court fixed the price of the shares at $1.16 per share, resulting in a total value of $1,160,000. The Court noted that if the shares were not acquired by shareholders, the company would be ordered to buy back the remaining shares, and if the acquisition was not successful, the company would be wound up. The Court deferred consideration of other remedies to allow the shareholders and the company to purchase the plaintiff's shares. The Court found that the defendants' conduct of the proceedings was contrary to the overarching purpose of the civil practice and procedure provisions of the Federal Court of Australia Act 1976 (Cth) and the Federal Court Rules 2011 (Cth), and therefore, an indemnity costs order should be made against the defendants. The Court found that no costs order should be made against the second to fourth defendants as no other order was made against them. The Court's decision was based on the legal principles and authorities relevant to the case, and the binding legal principle established is that the appropriate remedy under s 233 of the Corporations Act 2001 (Cth) in this case is for the plaintiff and the first defendant to complete the sale of the plaintiff's shares to any interested existing shareholders and persons who have signed an undertaking at a price of $1.16 per share.